With an array of on-going medical conferences in both North America and International locations to choose from, physicians are left wondering which conferences offer the best opportunity to engage with their peers and experts, while pharmaceutical companies question which conferences are seen as offering the most value.
We surveyed 151 Canadian and 150 US physicians to better understand individual conference attendance and the perceived overall value of the conferences attended.
Read More
While most physicians have attended a conference over the past twelve months, the perceived overall value of each conference varies greatly. Often, the conference with the highest attendance is not seen as the conference providing the most value. In fact, for most specialties, the most attended does not equate to the most valued.
There are a few cases where high attendance does align with high value. For example, among U.S. Cardiologists, the American College of Cardiology conference had the highest attendance and rated as having the greatest overall value relative to other conferences attended by Cardiologists. Among Canadian Hematological Oncologists, the American Society of Hematology conference was the most often attended and was perceived as providing the most value.
Given that attendance and value do not often align, pharmaceutical companies should focus on how they engage with physicians at conferences and strive to provide a valuable and compelling experience for physicians whenever possible – this is most often driven by the ability to provide practical support and information that is relevant to their practice.